Journal of Dermatological Treatment (Feb 2022)

Assessment of the benefit of achieving complete versus almost complete skin clearance in psoriasis: a patient’s perspective

  • Neil J. Korman,
  • William Malatestinic,
  • Orin M. Goldblum,
  • Mwangi J. Murage,
  • Lisa Renda,
  • Chen-Yen Lin,
  • James Lucas,
  • Chloe Middleton,
  • Steven Lobosco

DOI
https://doi.org/10.1080/09546634.2020.1772454
Journal volume & issue
Vol. 33, no. 2
pp. 733 – 739

Abstract

Read online

Background Psoriasis is characterized by thick and scaly plaques. The Dermatology Life Quality Index (DLQI) and Physician Global Assessment (PGA) can be used to define its severity. Objective To assess the impact of complete clearance of skin versus almost clear skin across various disease measures. Methods Data were collected in a survey of US dermatologists and patients with psoriasis from November 2016–January 2017. Dermatologists completed a 6-point PGA (0 = clear skin, 1 = almost clear skin). Patients completed the DLQI and Work Productivity and Activity Impairment questionnaire (WPAI). Patients with clear and almost clear skin were compared using analysis of covariance for continuous variables, and multivariate logistic regression analysis for categorical variables. Results Data for 99 and 160 patients with clear and almost clear skin, respectively, were included in the analyses. Patients with clear skin reported less frequent and lower intensity itching, lower total DLQI score (indicating better health-related quality of life), and less impairment of overall work productivity than patients with almost clear skin (all: p < 0.05). Limitations Limitations relating to general survey methodology. Conclusion Patients perceived a meaningful difference between clear and almost clear skin. Clear skin is now a realistic treatment target with newer biologics approved in psoriasis.

Keywords